Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,690 | 299 | 97.5% |
| Education | $95.75 | 2 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $919.78 | 54 | $0 (2024) |
| Lundbeck LLC | $610.83 | 88 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $509.74 | 52 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $409.64 | 24 | $0 (2024) |
| ITI, Inc. | $303.97 | 16 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $199.72 | 16 | $0 (2022) |
| Alkermes, Inc. | $149.45 | 8 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $135.75 | 10 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $114.27 | 8 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $101.03 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $857.24 | 70 | Otsuka America Pharmaceutical, Inc. ($223.05) |
| 2023 | $712.06 | 59 | Lundbeck LLC ($183.04) |
| 2022 | $1,552 | 109 | ABBVIE INC. ($618.93) |
| 2021 | $664.38 | 63 | AbbVie Inc. ($173.52) |
All Payment Transactions
301 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: CNS | ||||||
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $7.38 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $7.74 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $7.36 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Neurology | ||||||
| 11/20/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $7.94 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $19.07 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $6.44 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $2.08 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $9.86 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/30/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $9.82 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $7.36 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2024 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $7.32 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $3.69 | General |
| Category: PSYCHIATRY | ||||||
| 09/04/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $7.58 | General |
| Category: PSYCHIATRY | ||||||
| 08/28/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $9.39 | General |
| Category: PSYCHIATRY | ||||||
| 08/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Neuropsychiatry | ||||||
| 08/21/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $6.64 | General |
| Category: PSYCHIATRY | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.29 | General |
| Category: PSYCHIATRY | ||||||
| 08/14/2024 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $7.24 | General |
| Category: PSYCHIATRY | ||||||
| 08/14/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $2.86 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 58 | 97 | $10,690 | $5,287 |
| 2022 | 2 | 62 | 128 | $14,113 | $7,193 |
| 2021 | 1 | 26 | 40 | $4,891 | $3,192 |
| 2020 | 1 | 30 | 34 | $3,644 | $1,035 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 58 | $7,410 | $3,878 | 52.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 39 | $3,279 | $1,409 | 43.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 89 | $10,882 | $5,526 | 50.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 39 | $3,231 | $1,667 | 51.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 40 | $4,891 | $3,192 | 65.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 30 | 34 | $3,644 | $1,035 | 28.4% |
About Ryan Bednar
Ryan Bednar is a Psychiatric/Mental Health healthcare provider based in Medina, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2018. The National Provider Identifier (NPI) number assigned to this provider is 1376015594.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ryan Bednar has received a total of $3,786 in payments from pharmaceutical and medical device companies, with $857.24 received in 2024. These payments were reported across 301 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,690).
As a Medicare-enrolled provider, Bednar has provided services to 176 Medicare beneficiaries, totaling 299 services with total Medicare billing of $16,707. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Medina, OH
- Active Since 12/28/2018
- Last Updated 12/28/2018
- Taxonomy Code 363LP0808X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1376015594
Products in Payments
- VRAYLAR (Drug) $919.78
- ABILIFY MAINTENA (Drug) $741.09
- CAPLYTA (Drug) $439.72
- REXULTI (Drug) $314.42
- INVEGA SUSTENNA (Drug) $291.62
- LATUDA (Drug) $199.72
- ARISTADA (Drug) $131.37
- SPRAVATO (Drug) $105.07
- INGREZZA (Drug) $101.03
- Auvelity (Drug) $93.91
- TRINTELLIX (Drug) $65.23
- SECUADO (Drug) $52.50
- Austedo XR (Drug) $48.82
- AUSTEDO (Drug) $37.09
- ABILIFY ASIMTUFII (Drug) $36.04
- QELBREE (Drug) $30.26
- BRINTELLIX (Drug) $29.02
- UZEDY (Drug) $28.36
- FANAPT (Drug) $25.29
- COBENFY (Drug) $19.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Medina
Mrs. Nicole Johnson, Cnp, CNP
Psychiatric/Mental Health — Payments: $4,378
Charissa Duffy, Aprn, APRN
Psychiatric/Mental Health — Payments: $3,948
Alexandra Flanigan
Psychiatric/Mental Health — Payments: $2,415
Jacquelynn Hoffman, Aprn-Cnp, APRN-CNP
Psychiatric/Mental Health — Payments: $1,907
Dr. Theresa Roberts, Dnp, Pmhnp-Bc, DNP, PMHNP-BC
Psychiatric/Mental Health — Payments: $1,568
Amy Rocco, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $1,449